FMC stock reflects Fresenius Medical Care's latest earnings base
Published on 07/27/2026 at 16:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
FMC stock (Fresenius Medical Care AG, ISIN DE0005785802) is anchored by €19.35 billion in 2025 revenue and €4.43 billion in operating income, while the company has also kept its investor-relations page active for 2026 updates. The combination gives the shares a clear numbers base even without a fresh event in the search results.
Revenue and profit base
Fresenius Medical Care reported 2025 revenue of €19.35 billion and operating income of €4.43 billion, according to its latest investor context. Those figures set the core earnings reference for FMC stock and frame how investors judge any new trading update against the 2025 starting point.
The company also reported a net income result of €1.08 billion for 2025, which gives a third dated metric for the valuation discussion. For comparison, that profit figure is materially below revenue but still marks a clear full-year earnings base for the dialysis group.
What the 2025 numbers say
The 2025 revenue figure of €19.35 billion and operating income of €4.43 billion create a margin picture that matters more than a single headline move. The ratio of operating income to revenue is about 22.9%, using the 2025 figures already reported by Fresenius Medical Care.
That is the most useful comparison in the available data: it links the top line to operating profitability and shows why future updates on cost control and treatment volumes matter. FMC stock therefore trades on execution quality as much as on revenue size.
Full Fresenius Medical Care investor context
The companys investor-relations hub remains the central source for earnings, guidance, and capital-markets updates tied to the 2025 and 2026 reporting cycle.
Dialysis remains the product core
Fresenius Medical Care's core business is dialysis and related renal-care services, which is the product and service base behind the 2025 figures. That operating mix is why the companys revenue and operating income data matter more than a simple branding story.
In practical terms, the business line is visible in the numbers already published for 2025: €19.35 billion in revenue, €4.43 billion in operating income, and €1.08 billion in net income. Those are the three dated metrics that define the current financial backdrop for FMC stock.
Stock level and venue
FMC stock is listed in Frankfurt and is tracked by investors through the companys German market listing. A current trading price was not included in the search results, so the cleanest market context here is the published 2025 profit and revenue base rather than an unverified quote.
That leaves the investment lens on the reported 2025 figures, not on a short-term price move. For readers following FMC stock, the next useful benchmark is the next scheduled investor update on the companys IR channel.
FMC at a glance
- Company: Fresenius Medical Care AG
- ISIN: DE0005785802
- Ticker: XETRA: FME
- Trading venue: Xetra
- Sector / Industry: Health Care Equipment & Supplies
- Index membership: DAX
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
